Seres Therapeutics, Inc. (47)

Browse by Contract Category

Contracts

First Amendment to Lease, dated December 9, 2022, by and between Seres Therapeutics, Inc. and BMR-Sidney Research Campus, LLC (f/k/a BMR 200-Sidney Street LLC) (Filed With SEC on December 14, 2022)
Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended (Filed With SEC on November 2, 2022)
Non-Employee Director Compensation Program (Filed With SEC on August 3, 2022)
Form of Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)
Amendment No. 1 to License Agreement, dated March 24, 2022, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on May 4, 2022)
Long Term Manufacturing Agreement, dated November 8, 2021, by and between the Registrant and BacThera AG (Filed With SEC on March 1, 2022)
Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC (Filed With SEC on June 30, 2022)
Form of Non-Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)
Second Amendment to Loan and Security Agreement, dated February 24, 2022 by and between the Registrant and Hercules Capital, Inc (Filed With SEC on March 1, 2022)
Employment Agreement, dated January 5, 2022, by and between the Registrant and Paula Cloghessy (Filed With SEC on March 1, 2022)
License Agreement, dated July 1, 2021, by and between the Registrant and NHSc Pharma Partners (Filed With SEC on November 10, 2021)
Non-Employee Director Compensation Program (Filed With SEC on November 10, 2021)
Letter Agreement, dated November 4, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on November 10, 2021)
Non-Employee Director Compensation Program (Filed With SEC on August 3, 2021)
Amended and Restated Employment Agreement, dated as of January 29, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on August 3, 2021)
Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on May 21, 2021)
Employment Agreement, dated May 10, 2021, by and between Seres Therapeutics, Inc. and David Arkowitz (Filed With SEC on May 20, 2021)
Description of Capital Stock (Filed With SEC on March 2, 2021)
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Lisa von Moltke, M.D (Filed With SEC on March 2, 2021)
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Teresa L. Young (Filed With SEC on March 2, 2021)
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and David S. Ege, Ph.D (Filed With SEC on March 2, 2021)
Non-Employee Director Compensation Program (Filed With SEC on March 2, 2021)
2015 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on March 2, 2021)
Second Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Matthew R. Henn, Ph.D (Filed With SEC on February 1, 2021)
Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Thomas J. DesRosier (Filed With SEC on February 1, 2021)
Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Eric D. Shaff (Filed With SEC on February 1, 2021)
Employment Agreement, dated October 13, 2020, by and between the Registrant and David S Ege (Filed With SEC on November 9, 2020)
Securities Purchase Agreement, dated August 12, 2020, between the Company and Socit des Produits Nestl S.A (Filed With SEC on August 14, 2020)
Underwriting Agreement, dated August 12, 2020, between the Company and Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (Filed With SEC on August 14, 2020)
Employment Agreement, dated June 8, 2020, by and between the Registrant and Teresa L. Young (Filed With SEC on July 28, 2020)
First Amendment to Loan and Security Agreement by and between the Registrant and Hercules Capital, Inc., dated April 16, 2020 (Filed With SEC on July 28, 2020)
Employment Agreement, dated April 2, 2020, by and between the Registrant and Lisa von Moltke, M.D (Filed With SEC on May 7, 2020)
Letter Amendment to Employment Agreement, dated April 8, 2020, by and between the Registrant and John Aunins (Filed With SEC on May 7, 2020)
Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)
Description of Capital Stock (Filed With SEC on March 2, 2020)
Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz (Filed With SEC on March 2, 2020)
Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)
Sublease Agreement dated July 1, 2019, by and between the Registrant and Flagship VL56, Inc. and Flagship VL58, Inc (Filed With SEC on November 5, 2019)
Employment Agreement, dated July 11, 2019, by and between the Registrant and Marcus Chapman (Filed With SEC on November 5, 2019)
Loan and Security Agreement dated October 29, 2019 between Seres Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on November 4, 2019)
Amended and Restated Employment Agreement, dated March 25, 2019, by and between the Registrant and Matthew Henn (Filed With SEC on August 6, 2019)
Underwriting Agreement, dated June 13, 2019, between the Company and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 14, 2019)
Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC (Filed With SEC on May 2, 2019)
Letter Agreement dated October 30, 2018, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)
Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd (Filed With SEC on March 6, 2019)
Amended and Restated Employment Agreement, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Eric D. Shaff (Filed With SEC on January 15, 2019)
Separation Agreement and Release, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Roger Pomerantz (Filed With SEC on January 15, 2019)